Search Results 341-350 of 18179 for monoclonal antibody

1. Eculizumab (intravenous route) - Side effects & uses - Mayo Clinic

   Eculizumab injection is a monoclonal antibody that works on the immune system. This medicine is available only under a restricted distribution program called ...

2. Hematology - Clinical trials

   Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...

3. Study To Investigate The Safety And Effectiveness Of Two Doses Of The Antibody Drug GSK2857916 In Relapsed/Refractory Multiple Myeloma Patients - Mayo Clinic

   Prior treatment with a monoclonal antibody within 30 days of receiving the first dose of study drugs. Prior BCMA targeted therapy. Evidence of active ...

4. A First-in-Human, Phase 1 Dose-Escalation And Cohort Expansion Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of BJ-005 In Patients With Advanced Solid Tumor Or Lymphoma - Mayo Clinic

   BJ-005 is a recombinant bifunctional molecule, composed of a humanized anti-PD-L1 IgG1 monoclonal antibody (mAb) fused with a portion of the ...

5. Acute Lymphocytic Leukemia Clinical Trials - Mayo Clinic Research

   Monoclonal antibodies, such as blinatumomab, may block cancer growth in different ways by targeting certain cells. It is not yet known whether combination ...

6. Medical Research & Education - Mayo Clinic News Network

   Monoclonal antibody therapy for COVID-19 safe for transplant patients featured image. COVID-19. Monoclonal antibody therapy for COVID-19 safe for transplant ...

7. Medulloblastoma Clinical Trials - Mayo Clinic Research

   Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

8. Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer - Mayo Clinic

   Monoclonal antibodies, such ... No prior treatment with an immune checkpoint inhibitor (anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CTLA4 monoclonal antibody).

9. Pembrolizumab With Or Without Anetumab Ravtansine In Treating Patients With Mesothelin-Positive Pleural Mesothelioma - Mayo Clinic

   Monoclonal antibodies, such as anetumab ... Patients who have received any monoclonal antibody therapy within 4 weeks prior to entering the study.

10. Health Topics - Mayo Clinic News Network

    What's the latest on monoclonal antibody therapies to treat COVID-19? Adam Harringa. January 12, 2022. What is 'flurona' and why ...